Small Molecules Acquired in 2021 M&A: Deep Dive

There were 16 acquisitions of companies with small molecule drug assets in 2021 and one merger. Here is a more in-depth look into all of the lead small molecules acquired in 2021, including a review of: 

• The lead molecules in each acquisition and their structural representations where disclosed
• The mechanism of action, stage, and indication of each lead molecule
• Relevant clinical data and rationale for each acquisition

Navigate the 2021 M&A Series

• the top overall drug discovery M&A transactions by value (Part 1)
• the transactions with disclosed upfront payments (Part 2)
• the most valuable small molecule acquisitions (Part 3)
• the most valuable large molecule transactions (Part 4)